Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Silberstein

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Arquivos De Neuro-Psiquiatria|June 23, 2016
Botulinum neurotoxin type-A when utilized in animals with trigeminal sensitization induced a antinociceptive effectElcio J Piovesan, Michael Oshinsky, Stephen Silberstein, et al.
Headache|June 11, 2011
Diagnostic criteria for headache due to spontaneous intracranial hypotension: a perspectiveWouter I Schievink, David W Dodick, Bahram Mokri, et al.
Headache|March 21, 2007
Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineursJay Goldberg, Abigail Wolf, Stephen Silberstein, et al.
Headache|October 1, 2009
Safety and tolerability of short-term preventive frovatriptan: a combined analysisE Anne MacGregor, Jan L Brandes, Stephen Silberstein, et al.
Headache|September 23, 2023
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective studyVictor S Wang, Justin Kosman, Hsiangkuo Yuan, et al.
Headache|May 13, 2017
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered<sup>®</sup> Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral SumatriptanStephen Silberstein, Paul K Winner, Peter J McAllister, et al.
Headache|April 21, 2007
Patients' preference for migraine preventive therapyMario Fernando Prieto Peres, Stephen Silberstein, Frederico Moreira, et al.
Headache|October 13, 2009
Expanding access to triptans: assessment of clinical outcomeRoger K Cady, Jerome Goldstein, Stephen Silberstein, et al.
Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.
Cephalalgia : an International Journal of Headache|October 17, 2025
Migraine-related disability according to headache frequency subclassifications: A systematic review and meta-analysisManjit Singh Matharu, Stephen Silberstein, Hsiangkuo Yuan, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Arquivos De Neuro-Psiquiatria|June 23, 2016
Botulinum neurotoxin type-A when utilized in animals with trigeminal sensitization induced a antinociceptive effectElcio J Piovesan, Michael Oshinsky, Stephen Silberstein, et al.
Headache|June 11, 2011
Diagnostic criteria for headache due to spontaneous intracranial hypotension: a perspectiveWouter I Schievink, David W Dodick, Bahram Mokri, et al.
Headache|March 21, 2007
Evaluation of an electronic diary as a diagnostic tool to study headache and premenstrual symptoms in migraineursJay Goldberg, Abigail Wolf, Stephen Silberstein, et al.
Headache|October 1, 2009
Safety and tolerability of short-term preventive frovatriptan: a combined analysisE Anne MacGregor, Jan L Brandes, Stephen Silberstein, et al.
Headache|September 23, 2023
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective studyVictor S Wang, Justin Kosman, Hsiangkuo Yuan, et al.
Headache|May 13, 2017
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered<sup>®</sup> Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral SumatriptanStephen Silberstein, Paul K Winner, Peter J McAllister, et al.
Headache|April 21, 2007
Patients' preference for migraine preventive therapyMario Fernando Prieto Peres, Stephen Silberstein, Frederico Moreira, et al.
Headache|October 13, 2009
Expanding access to triptans: assessment of clinical outcomeRoger K Cady, Jerome Goldstein, Stephen Silberstein, et al.
Cephalalgia : an International Journal of Headache|June 26, 2019
Eptinezumab for prevention of chronic migraine: A randomized phase 2b clinical trialDavid W Dodick, Richard B Lipton, Stephen Silberstein, et al.
Cephalalgia : an International Journal of Headache|October 17, 2025
Migraine-related disability according to headache frequency subclassifications: A systematic review and meta-analysisManjit Singh Matharu, Stephen Silberstein, Hsiangkuo Yuan, et al.
Pageof 9